Digital Platforms as a Key Factor of the Medical Organizations Activities Development

Shlyakhto, Evgeny; Ilin, Igor; Iliashenko, Oksana; Karaptan, Ditrii; Tick, Andrea

doi:10.1007/978-3-030-93872-7_27

Cited by 4 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With the advent of the ability to use robotic technology, cell and genetic engineering and other information technologies, a new direction in the development of medicine has emerged, namely hightech medical organizations (HMO). Such medical organizations become parts of clusters and hubs, develop at the ecosystem level and implement integrated platform solutions [1,2]. This, in turn, forms a whole cluster of special medical equipment.…”

Section: Introductionmentioning

confidence: 99%

Life-Cycle Contract as an Innovative Business Model for High-Tech Medical Organizations

Ilin

Levina

Frolov

et al. 2022

Journal of Open Innovation: Technology, Market, and Complexity

View full text Add to dashboard Cite

The active digitalization of the healthcare system has given impetus to the emergence of a new type of enterprise—high-tech medical organizations (HMO). Their main distinguishing feature is the use of innovative high-tech medical equipment. However, the high cost of this equipment has become a factor slowing down the development of such organizations. This paper considers the life-cycle contract (LCC) as a special form of interaction between stakeholders and investments throughout the life cycles of equipment. Moreover, to provide technological support, continuous acquisition and life-cycle support (CALS) technologies, which are based on the same principles of working with the life cycle as LCC, are proposed. This question turned out to be a significant research gap, which was not sufficiently reflected in the available world studies. Thus, the aim of the current study is to describe the features of the use of LCC for HMO using CALS technologies and the impact of the life cycle of high-tech medical equipment on LCC, as well as to present the innovative component of the proposed model. Based on the analysis of the literature and the best world practices, the authors propose a visualization of the interaction of all stakeholders within the LCC for HMO. Such a decision is extremely relevant for developing organizations, public authorities and investors around the world.

show abstract

Section: Introductionmentioning

confidence: 99%